Detalhe da pesquisa
1.
Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: A single-center experience.
Pediatr Transplant
; 24(3): e13692, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32202691
2.
Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults.
Transplantation
; 106(2): 412-419, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33795598
3.
Pneumatosis intestinalis after hematopoietic stem cell transplantation: When not doing anything is good enough.
J Pediatr Surg
; 56(11): 2073-2077, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33455803
4.
Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD.
Bone Marrow Transplant
; 59(3): 425-427, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38182673
5.
Evidence-based care of the child with deformational plagiocephaly, Part I: assessment and diagnosis.
J Pediatr Health Care
; 26(4): 242-50; quiz 251-3, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22726709
6.
Evidence-based care of the child with deformational plagiocephaly, part II: management.
J Pediatr Health Care
; 26(5): 320-31, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22920774